GlassScriptPhysician profile
Jacqueline A Stephen
NPI 1659428183
$1,886.29
in general payments reported to CMS, 2019-2025
14 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $331 · 2021: $327 · 2022: $317 · 2023: $308 · 2024: $168 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $701.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $496.02 | 2022-2025 | Lo Loestrin Fe, Liletta |
| Avion Pharmaceuticals | $409.36 | 2019-2021 | |
| Therapeuticsmd, INC. | $181.35 | 2019-2022 | |
| Exeltis, USA INC. | $145.95 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $112.93 | 2020-2025 | |
| Pfizer INC. | $104.88 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $101.82 | 2023-2025 | |
| Allergan, INC. | $81.17 | 2019-2020 | |
| Coopersurgical, INC. | $68.70 | 2019-2025 | Paragard T 380a |
| Lupin INC. | $49.45 | 2019-2020 | |
| Astellas Pharma US INC | $43.60 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $38.79 | 2023-2025 | Thinprep 2000 Processor, Aptima |
| Merck Sharp & Dohme LLC | $35.58 | 2019-2023 | Gardasil 9 |
| Millicent US INC | $16.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Stephen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.